EC Number   |
Inhibitors |
Structure |
|---|
   1.14.99.29 | 2,3-Dihydroxybenzoic acid |
slight inhibition at 2 mM |
   |
| 1.14.99.29 | 2-(2-hydroxy-5-methylphenyl)-1,3-thiazole-4-carboxylic acid |
inhibition in vitro and in cells |
|
| 1.14.99.29 | 2-(2-hydroxy-5-methylphenyl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid |
inhibition in vitro and in cells |
|
| 1.14.99.29 | 2-(4-methoxyphenyl)-6-[[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]methyl]-1H-benzimidazole |
94.1% inhibition at 0.002 mM |
|
| 1.14.99.29 | 3,4-dihydroxybenzoic acid |
above 50% inhibition at 2 mM |
|
| 1.14.99.29 | 4,6-diphenyl-1-hydroxy-pyridine-2-one |
IC50 0.0007 mM |
|
| 1.14.99.29 | alkyl 4-oxo-piperidine 3 carboxylates |
structurally related to dihydropyrimidines, most potent, putative DOHH inhibitors in vitro |
|
| 1.14.99.29 | CaCl2 |
98% of initial activity at 0.005 mM |
|
| 1.14.99.29 | cadaverine |
87% of initial activity at 0.5 mM |
|
| 1.14.99.29 | caldine |
47% of initial activity at 0.5 mM |
|
